All news articles for March 2017

iStock/daboost

update - US FDA confirms lifting of import alert

Sun says US FDA poised to lift Mohali import alert

By Gareth Macdonald

Sun Pharmaceutical Industries Ltd has said the US FDA plans to lift the import alert imposed on its manufacturing plant in Mohali, Punjab in India.

Charles River re-ups Chiesi drug discovery contract

Charles River re-ups Chiesi drug discovery contract

By Melissa Fassbender

Charles River Laboratories has extended its integrated respiratory program with Chiesi Farmaceutici, through which it identifies and tests candidates for preclinical development.

SRI secures $90m BARDA contract

SRI secures $90m BARDA contract

By Melissa Fassbender

SRI International will advance compounds with the potential to treat persons exposed to biological, radiation, nuclear, and chemical agents – in a deal worth up to $90m.

Certara expands PBPK simulator availability

Certara expands PBPK simulator availability

By Melissa Fassbender

Certara has developed a new licensing approach, which provides smaller organizations access to its physiologically-based pharmacokinetic (PBPK) modeling and simulation platform.

CRO insourcing to gain momentum, says NovAliX

CRO insourcing to gain momentum, says NovAliX

By Melissa Fassbender

NovAliX has signed an insourcing agreement with UCB Biopharma, a model that the CRO says “energizes scientific organization” and offers "significant" cost advantages. 

Cerveau tapped for Alzheimer's research

Cerveau tapped for Alzheimer's research

By Melissa Fassbender

Cerveau has signed a research agreement through which it will supply its early-stage imaging agent to assess the stages of Alzheimer’s disease and other neurodegenerative diseases.

Top strategies for retaining CRA talent

Q&A

Top strategies for retaining CRA talent

By Melissa Fassbender

High turnover rates among clinical research associates (CRA) continue to plague the industry – and competence and staff engagement are the "crux" of the issue, says IAOCR.

NIH extends PPD HIV research support contract until 2024

NIH extends PPD HIV research support contract until 2024

By Melissa Fassbender

The renewed contract covers a range of research related services, including monitoring therapeutic trials, prevention trials, and vaccines work, with the ultimate goal of an "AIDS-free generation."